204 related articles for article (PubMed ID: 8670289)
1. Endothelin-converting enzyme: substrate specificity and inhibition by novel analogs of phosphoramidon.
Keller PM; Lee CP; Fenwick AE; Atkinson ST; Elliott JD; DeWolf WE
Biochem Biophys Res Commun; 1996 Jun; 223(2):372-8. PubMed ID: 8670289
[TBL] [Abstract][Full Text] [Related]
2. Purification and characterization of a phosphoramidon-sensitive endothelin-converting enzyme in porcine aortic endothelium. OFF.
Ohnaka K; Takayanagi R; Nishikawa M; Haji M; Nawata H
J Biol Chem; 1993 Dec; 268(35):26759-66. PubMed ID: 8253812
[TBL] [Abstract][Full Text] [Related]
3. Characterization of phosphoramidon-sensitive metalloproteinases with endothelin-converting enzyme activity in porcine lung membrane.
Sawamura T; Shinmi O; Kishi N; Sugita Y; Yanagisawa M; Goto K; Masaki T; Kimura S
Biochim Biophys Acta; 1993 Feb; 1161(2-3):295-302. PubMed ID: 8431480
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of endothelin converting activity from EAHY 926 cells: evidence for the physiologically relevant human enzyme.
Waxman L; Doshi KP; Gaul SL; Wang S; Bednar RA; Stern AM
Arch Biochem Biophys; 1994 Jan; 308(1):240-53. PubMed ID: 8311460
[TBL] [Abstract][Full Text] [Related]
5. Phosphoramidon, a metalloproteinase inhibitor, suppresses the secretion of endothelin-1 from cultured endothelial cells by inhibiting a big endothelin-1 converting enzyme.
Ikegawa R; Matsumura Y; Tsukahara Y; Takaoka M; Morimoto S
Biochem Biophys Res Commun; 1990 Sep; 171(2):669-75. PubMed ID: 2206130
[TBL] [Abstract][Full Text] [Related]
6. The endothelin-converting enzyme from human umbilical vein is a membrane-bound metalloprotease similar to that from bovine aortic endothelial cells.
Ahn K; Beningo K; Olds G; Hupe D
Proc Natl Acad Sci U S A; 1992 Sep; 89(18):8606-10. PubMed ID: 1528868
[TBL] [Abstract][Full Text] [Related]
7. Human breast cancer cells contain a phosphoramidon-sensitive metalloproteinase which can process exogenous big endothelin-1 to endothelin-1: a proposed mitogen for human breast fibroblasts.
Patel KV; Schrey MP
Br J Cancer; 1995 Mar; 71(3):442-7. PubMed ID: 7880721
[TBL] [Abstract][Full Text] [Related]
8. Endothelin-converting enzyme-2 is a membrane-bound, phosphoramidon-sensitive metalloprotease with acidic pH optimum.
Emoto N; Yanagisawa M
J Biol Chem; 1995 Jun; 270(25):15262-8. PubMed ID: 7797512
[TBL] [Abstract][Full Text] [Related]
9. Endothelin-2-converting enzyme from human renal adenocarcinoma cells is a phosphoramidon-sensitive, membrane-bound metalloprotease.
Shinmi O; Yorimitsu K; Moroi K; Nishiyama M; Sugita Y; Saito T; Inagaki Y; Masaki T; Kimura S
J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S61-4. PubMed ID: 7510000
[TBL] [Abstract][Full Text] [Related]
10. Endothelin-converting enzyme and its in vitro and in vivo inhibition.
Yano M; Okada K; Takada J; Hioki Y; Matsuyama K; Fukuroda T; Noguchi K; Nishikibe M; Ikemoto F
J Cardiovasc Pharmacol; 1991; 17 Suppl 7():S26-8. PubMed ID: 1725349
[TBL] [Abstract][Full Text] [Related]
11. Importance of the C-terminal region of big endothelin-1 for specific conversion by phosphoramidon-sensitive endothelin converting enzyme.
Okada K; Takada J; Arai Y; Matsuyama K; Yano M
Biochem Biophys Res Commun; 1991 Oct; 180(2):1019-23. PubMed ID: 1953706
[TBL] [Abstract][Full Text] [Related]
12. Effects of metalloprotease inhibitors on the conversion of proendothelin-1 to endothelin-1.
Trapani AJ; Balwierczak JL; Lappe RW; Stanton JL; Graybill SC; Hopkins MF; Savage P; Sperbeck DM; Jeng AY
Biochem Mol Biol Int; 1993 Dec; 31(5):861-7. PubMed ID: 8136704
[TBL] [Abstract][Full Text] [Related]
13. Phosphoramidon-sensitive endothelin-converting enzyme in the cytosol of cultured bovine endothelial cells.
Takada J; Okada K; Ikenaga T; Matsuyama K; Yano M
Biochem Biophys Res Commun; 1991 Apr; 176(2):860-5. PubMed ID: 2025297
[TBL] [Abstract][Full Text] [Related]
14. A simple method for measurement of phosphoramidon-sensitive endothelin converting enzyme activity.
Matsumura Y; Umekawa T; Kawamura H; Takaoka M; Robinson PS; Cook ND; Morimoto S
Life Sci; 1992; 51(20):1603-11. PubMed ID: 1435068
[TBL] [Abstract][Full Text] [Related]
15. Effects of phosphoramidon on endothelin-1 and big endothelin-1 production in human aortic endothelial cells.
Matsumura Y; Tsukahara Y; Kojima T; Murata S; Murakami A; Takada K; Takaoka M; Morimoto S
Biol Pharm Bull; 1995 Mar; 18(3):401-6. PubMed ID: 7550091
[TBL] [Abstract][Full Text] [Related]
16. Molecular pharmacology of endothelin converting enzymes.
Turner AJ; Murphy LJ
Biochem Pharmacol; 1996 Jan; 51(2):91-102. PubMed ID: 8615890
[TBL] [Abstract][Full Text] [Related]
17. Identification and partial purification of a thiol endothelin-converting enzyme from porcine aortic endothelial cells.
Deng Y; Savage P; Shetty SS; Martin LL; Jeng AY
J Biochem; 1992 Mar; 111(3):346-51. PubMed ID: 1587796
[TBL] [Abstract][Full Text] [Related]
18. Effects of metalloprotease inhibitors on smooth muscle endothelin-converting enzyme activity.
Balwierczak JL; Kukkola PJ; Savage P; Jeng AY
Biochem Pharmacol; 1995 Jan; 49(3):291-6. PubMed ID: 7857315
[TBL] [Abstract][Full Text] [Related]
19. Phosphoramidon blocks the pressor activity of porcine big endothelin-1-(1-39) in vivo and conversion of big endothelin-1-(1-39) to endothelin-1-(1-21) in vitro.
McMahon EG; Palomo MA; Moore WM; McDonald JF; Stern MK
Proc Natl Acad Sci U S A; 1991 Feb; 88(3):703-7. PubMed ID: 1992461
[TBL] [Abstract][Full Text] [Related]
20. Phosphoramidon blocks the pressor activity of big endothelin[1-39] and lowers blood pressure in spontaneously hypertensive rats.
McMahon EG; Palomo MA; Moore WM
J Cardiovasc Pharmacol; 1991; 17 Suppl 7():S29-33. PubMed ID: 1725358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
